Drug intelligence / Profile preview

Baofukang

Development stage
Unknown
Lead developer
Peking University People's Hospital
Administration
Vaginal
01

Overview

Baofukang is a traditional Chinese medicine (TCM) preparation, typically formulated as a vaginal suppository, used for the treatment of human papillomavirus (HPV) infections and various types of vaginitis. Its primary active components are Zedoary Turmeric Oil (derived from *Curcuma phaeocaulis*) and Borneol. Baofukang is described as having "estrogen-like" effects, which help to increase vaginal glycogen levels and improve the health of the vaginal mucosa. This action promotes the growth of beneficial Lactobacillus species, thereby restoring a healthy vaginal microenvironment that facilitates the clearance of persistent high-risk HPV (hr-HPV). Additionally, the drug exhibits direct antiviral, anti-inflammatory, and anti-fungal properties. It is frequently studied and used in clinical practice in China, both as a monotherapy and in combination with recombinant human interferon alpha-2b or probiotic preparations to enhance clinical efficacy in treating cervical HPV infections and preventing progression to high-grade intraepithelial lesions.

Brand names
Baofukang
Other names
Baofukang suppositoryBaofukang栓
02

Targets

ER (Estrogen receptor)

Beyond the preview

Go deeper on Baofukang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baofukang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call